feed,title,long_url,short_url
RS,"Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients",https://www.researchsquare.com/article/rs-100994/latest,https://j.mp/3kWaZJ1
